
Proposed Government changes to legislation will require businesses to track and trace all R&D expenditure if they want to continue …

AstraZeneca is the latest international firm to be accused of corporation tax avoidance, after an investigation claimed the firm is …

Tax rule changes coming from the US government have forced the collapse of a multi-billion dollar deal between Humira manufacturer …

AbbVie will reconsider its planned $54.6 billion takeover of Shire in light of new US proposals designed to curb companies …

US-based medical technology firm Steris Corporation is to purchase Synergy Health in the UK for $1.9 billion and will shift …
The UK life sciences industry will benefit from a cut in corporation tax and additional funding for academic research. The …
AstraZeneca has sorted out a decade-long dispute over its tax affairs by agreeing to pay out $1.1 billion this year. …
Over the last two decades technology has allowed companies to greatly increase their global reach. Within the pharmaceutical sector it …

George Osborne’s first Budget as chancellor has had a mixed reception from the pharma and biotech sectors. The BioIndustry Association …
The pharma and healthcare sectors have been unpicking the implications of last week’s Pre-Budget Report (PBR) by chancellor Alastair Darling.The …